Abstract:Importance: More patients are opting for telemedicine because of its convenience and potential cost savings, especially post-COVID-19. This is also applicable to atopic dermatitis (AD).
Objective: To investigate telemedicine’s impact on the care of patients with AD.
Methods: Relevant articles from five databases—namely, MEDLINE, Embase, Scopus, CINAHL, and the Cochrane Library—were searched up to August 1, 2023. Controlled prospective clinical trials, long-term follow-up studies, retrospective studies, and observational studies that assessed the effectiveness of telemedicine in terms of patient- and physician-reported outcomes of AD were included. A random-effects model was chosen to estimate all pooled data, with results presented in forest plots.
Results: Regarding teleconsultation, four studies reported decreases in Patient-Oriented Eczema Measure (POEM), Investigator Global Assessment, Scoring Atopic Dermatitis, and Dermatology Life Quality Index (DLQI), which were comparable with the control arm. For electronic interventions, POEM and Hand Eczema Severity Index significantly decreased from baseline in favor of telemedicine (P = 0.0003 and P < 0.00001, respectively), while no difference was observed for Eczema Area and Severity Index and DLQI.
Conclusions: Telemedicine can be a useful adjunct to traditional face-to-face consultations in AD but with potential cost savings and convenience for patients.
Get full access to this article
View all access options for this article.
References
1.
ImprovementQ. US department of health and human services health resources and services administration.
2.
JacquelineL, MariaV. Telemedicine use among adults: United States, 2021. Published online October 13, 2022; doi: 10.15620/cdc:121435
3.
Intan SabrinaM, DefiIR. Telemedicine guidelines in South East Asia—a scoping review. Front Neurol. 2020; 11:581649; doi: 10.3389/fneur.2020.581649
ShahAC, BadawySM. Telemedicine in pediatrics: Systematic review of randomized controlled trials. JMIR Pediatr Parent. 2021; 4(1):e22696; doi: 10.2196/22696
6.
MüllerKI, AlstadhaugKB, BekkelundSI. A randomized trial of telemedicine efficacy and safety for nonacute headaches. Neurology. 2017; 89(2):153–162; doi: 10.1212/wnl.000000000000408
BylundS, KobyletzkiL, SvalstedtM, et al.Prevalence and incidence of atopic dermatitis: A systematic review. Acta Derm Venereol. 2020; 100(12):adv00160; doi: 10.2340/00015555-3510
10.
OdeshiO, TurkT, FiorilloL, et al.Teledermatology versus in-person visits for the follow-up of atopic dermatitis patients. J Cutan Med Surg. 2024; 28(4):346–351; doi: 10.1177/12034754241253192
11.
CumpstonM, LiT, PageMJ, et al.Updated guidance for trusted systematic reviews: A new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019; 10(10):ED000142. Published online October 3; doi: 10.1002/14651858.ed000142
12.
GoldetG, HowickJ. Understanding grade: An introduction. J Evid Based Med. 2013; 6(1):50–54; doi: 10.1111/jebm.12018
13.
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan).
14.
ArmstrongAW, JohnsonMA, LinS, et al.Patient-centered, direct-access online care for management of atopic dermatitis. JAMA Dermatol. 2015; 151(2):154–160; doi: 10.1001/jamadermatol.2014.2299
15.
BergmoTS, WangbergSC, SchopfTR, et al.Web‐based consultations for parents of children with atopic dermatitis: Results of a randomized controlled trial. Acta Paediatr. 2009; 98(2):316–320; doi: 10.1111/j.1651-2227.2008.01033.x
16.
KornmehlH, SinghS, JohnsonMA, et al.Direct-access online care for the management of atopic dermatitis: A randomized clinical trial examining patient quality of life. Telemed J E Health. 2017; 23(9):726–732; doi: 10.1089/tmj.2016.0249
17.
RagaminA, de WijsLE, HijnenD, et al.Care for children with atopic dermatitis in the Netherlands during the Covid‐19 pandemic: Lessons from the first wave and implications for the future. J Dermatol. 2021; 48(12):1863–1870; doi: 10.1111/1346-8138.16130
18.
JoergensenKM, VestergaardC, JoergensenMS, et al.Memory buttons in combination with mobile application-induced objective and subjective effects in patients with atopic dermatitis. Dermatol Res Pract. 2020; 2020:8915893–8915896; doi: 10.1155/2020/8915893
19.
SanterM, MullerI, BecqueT, et al.Eczema care online behavioural interventions to support self-care for children and young people: Two independent, pragmatic, randomised controlled trials. BMJ. 2022; 379:e072007. Published online December 7; doi: 10.1136/bmj-2022-072007
20.
MollerupA, HarboeG, JohansenJD. User evaluation of patient counselling, combining nurse consultation and eHealth in hand eczema. Contact Dermatitis. 2016; 74(4):205–216; doi: 10.1111/cod.12534
21.
WeigandtWA, SchardtY, BruchA, et al.Impact of an eHealth smartphone app on quality of life and clinical outcome of patients with hand and foot eczema: Prospective Randomized Controlled Intervention Study. JMIR Mhealth Uhealth. 2023; 11:e38506; doi: 10.2196/38506
22.
SanterM, MullerI, YardleyL, et al.Supporting self-care for families of children with eczema with a web-based intervention plus health care professional support: Pilot randomized controlled trial. J Med Internet Res. 2014; 16(3):e70; doi: 10.2196/jmir.3035
23.
GudmundsdóttirSL, BallariniT, ÁmundadóttirML, et al.Clinical efficacy of a digital intervention for patients with atopic dermatitis: A prospective single-center study. Dermatol Ther (Heidelb). 2022; 12(11):2601–2611; doi: 10.1007/s13555-022-00821-y
24.
SingerHM, LevinLE, MorelKD, et al.Texting atopic dermatitis patients to optimize learning and eczema area and severity index scores: A pilot randomized control trial. Pediatr Dermatol. 2018; 35(4):453–457; doi: 10.1111/pde.13510
25.
van Os‐MedendorpH, KoffijbergH, Eland‐de KokPCM, et al.E‐health in caring for patients with atopic dermatitis: A randomized controlled cost‐effectiveness study of Internet‐Guided Monitoring and online self‐management training. Br J Dermatol. 2012; 166(5):1060–1068; doi: 10.1111/j.1365-2133.2012.10829.x
26.
PakH, TriplettCA, LindquistJH, et al.Store-and-forward teledermatology results in similar clinical outcomes to conventional clinic-based care. J Telemed Telecare. 2007; 13(1):26–30; doi: 10.1258/135763307779701185
27.
VermaL, TurkT, DennettL, et al.Teledermatology in atopic dermatitis: A systematic review. J Cutan Med Surg. 2024; 28(2):153–157; doi: 10.1177/12034754231223694
28.
EminovićN, DijkgraafMG, BerghoutRM, et al.A cost minimisation analysis in teledermatology: Model-based approach. BMC Health Serv Res. 2010; 10(1):251; doi: 10.1186/1472-6963-10-251
29.
Vidal-AlaballJ, Garcia DomingoJL, Garcia CuyàsF, et al.A cost savings analysis of asynchronous teledermatology compared to face-to-face dermatology in Catalonia. BMC Health Serv Res. 2018; 18(1):650; doi: 10.1186/s12913-018-3464-4
30.
LivingstoneJ, SolomonJ. An assessment of the cost-effectiveness, safety of referral and patient satisfaction of a General Practice Teledermatology Service. London J Prim Care (Abingdon). 2015; 7(2):31–35; doi: 10.1080/17571472.2015.11493433
31.
TensenE, van der HeijdenJP, JaspersMW, et al.Two decades of teledermatology: Current status and integration in National Healthcare Systems. Curr Dermatol Rep. 2016; 5(2):96–104; doi: 10.1007/s13671-016-0136-7
32.
RossJ, StevensonF, LauR, et al.Exploring the challenges of implementing e-health: A protocol for an update of a systematic review of reviews. BMJ Open. 2015; 5(4):e006773; doi: 10.1136/bmjopen-2014-006773
33.
RobbenSH, PerryM, HuisjesM, et al.Implementation of an innovative web-based conference table for community-dwelling frail older people, their informal caregivers and professionals: A process evaluation. BMC Health Serv Res. 2012; 12(1):251; doi: 10.1186/1472-6963-12-251
34.
Giavina-BianchiM, Giavina-BianchiP, SantosAP, et al.Accuracy and efficiency of telemedicine in atopic dermatitis. JAAD Int. 2020; 1(2):175–181; doi: 10.1016/j.jdin.2020.08.002
35.
World Health Organization. Global strategy on human resources for health: Workforce 2030.
